Scientific entrepreneurism project (expected establishment of NewCo by Q4 2023) focused on the development of a new technology platform for the delivery of nucleic acid therapeutics.
As a technology transference and valorization academic project from the Montenegro research group (Universidade de Santiago De Compostela / CIQUS), we have discovered a new peptide-based approach that enables efficient, non-toxic and targeted delivery of a wide variety of nucleic acids (mRNA, siRNA, pDNA) and proteins (Cas9). Robust in vitro and in vivo data suggest the potential for translation of this novel delivery technology into preclinical developments, which are currently being sought.
Company Details
- Employees
- 3
- Founded
- -
- Address
- Calle De Jenaro De La Fuente Domínguez, Ciqus,spain
- Industry
- Biotechnology
- Website
- http://www.traffikgene.com
- Keywords
- Santiago de Compostela.
- HQ
- Santiago de Compostela, Galicia
Traffikgene Questions
Traffikgene's website is http://www.traffikgene.com
Traffikgene's LinkedIn profile is https://es.linkedin.com/company/traffikgene
Traffikgene has
3 employees.
View email and phone details for 3
employees at Traffikgene.
Traffikgene's industry is
Biotechnology
Traffikgene's top competitors are
Lopita & Co.,
Smart To People (A Smart City Consulting),
Pentabiol,
Zanteris,
Car T-Rex Project,
Ciqus - Center For Research In Biological Chemistry And Molecular Materials,
Crossbrain,
Liberabio,
Healthtechtab - Healthtech Translation Advisory Board,
Ba International Partners.
Traffikgene's categories are Biotechnology
Traffikgene's founding year is 2023
